A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

When Nikki Myers, 33, found a lump in her neck last fall, she visited an urgent care clinic. She learned she had ovarian ...

New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with ...

US ovarian cancer mortality rates declined from 1999 to 2020, but significant disparities remain across age, race, and geographic regions, highlighting the need for targeted public health efforts.

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

Alshahrani, W. and Aladham, M. (2025) Excision of Remnant of Fallopian Tube at Vaginal Vault Mistaken for Granulation Tissue after Total Abdominal Hysterectomy: A Case Report. Advances in Sexual ...

ImmunoGen, Inc. has announced that its platinum-resistant ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) has been granted FDA accelerated approval.

“Ovarian cancer is a huge unmet need and more research in this area is critical as early diagnosis can mean the world of a difference for patient treatment,” says Inbal.

If you're looking to get pregnant, you may wonder how many eggs you have at various points in life. The short answer is: from millions to none.